KRI1
Protein KRI1 homolog
Also known as: FLJ12949, KRI1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N9T8
- Gene
- KRI1
- Ensembl
- ENSG00000129347
- Chromosome
- 19
- Canonical length
- 703 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
This gene overlaps with the gene for cysteine endopeptidase AUT-like 4 in a head-to-tail orientation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
703 residues, UniProt reviewed canonical sequence.
>Q8N9T8|KRI1
1 MPEPRGSSQL RVNAAFAARY NRYREREELQ RLKDRYGDRD SSSDSSSESD SSDERVEFDP
61 QQERDFYKTL SLLKKKDPRI YQKDATFYNR TASSSDSEED PEALEKQKKV RPMYLKDYER
121 KVILEKAGKY VDEENSDGET SNHRLQETSS QSYVEEQKQL KESFRAFVED SEDEDGAGEG
181 GSSLLQKRAK TRQEKAQEEA DYIEWLKGQK EIRNPDSLKE LTHLKEYWND PELDEGERFL
241 RDYILNKRYE EEEEEEEDEE EMEEEEGVHG PPVQLAVDDS SDEGELFLKK QEDFEQKYNF
301 RFEEPDSASV KTYPRSIASS VRRKDERRKE KREETRERKK REKAKKQEEL KQLKNLKRKE
361 ILAKLEKLRK VTGNEMLGLE EGDLEDDFDP AQHDQLMQKC FGDEYYGAVE EEKPQFEEEE
421 GLEDDWNWDT WDGPEQEGDW SQQELHCEDP NFNMDADYDP SQPRKKKREA PLTGKKKRKS
481 PFAAAVGQEK PVFEPGDKTF EEYLDEYYRL DYEDIIDDLP CRFKYRTVVP CDFGLSTEEI
541 LAADDKELNR WCSLKKTCMY RSEQEELRDK RAYSQKAQNS WKKRQVFKSL CREEAETPAE
601 ATGKPQRDEA GPQRQLPALD GSLMGPESPP AQEEEAPVSP HKKPAPQKRR RAKKARLLGP
661 TVMLGGCEFS RQRLQAFGLN PKRLHFRQLG RQRRKQQGPK NSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- retina: 31 nTPM
- thymus: 28 nTPM
- spleen: 22 nTPM
- skeletal muscle: 21 nTPM
- lymph node: 21 nTPM
- skin: 20 nTPM
Single-cell type
- megakaryocyte progenitors: 52 nCPM
- rod photoreceptor cells: 50 nCPM
- megakaryocyte-erythroid progenitors: 38 nCPM
- erythrocyte progenitors: 37 nCPM
- megakaryocytes: 37 nCPM
- pdcs: 34 nCPM
Immune cell
- plasmacytoid DC: 16 nTPM
- gdT-cell: 12 nTPM
- MAIT T-cell: 11 nTPM
- NK-cell: 10 nTPM
- memory CD8 T-cell: 9.7 nTPM
- naive CD8 T-cell: 9.5 nTPM
Brain region
- hypothalamus: 9.5 nTPM
- white matter: 9 nTPM
- choroid plexus: 8.7 nTPM
- medulla oblongata: 8.3 nTPM
- cerebral cortex: 8.2 nTPM
- basal ganglia: 7.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.14
- DepMap mean gene effect
- -1.03
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- LSU-rRNA)
- endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA
- 5.8S rRNA
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- KRR1 interacting protein 1
- Kri1-like, C-terminal
- KRI1-like family
- KRI1-like family C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRI1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRI1 as an antibody target. Whether an autoantibody or antibody against KRI1 could matter depends on whether native KRI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRI1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KRI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...